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An Audit of Changes in Outcomes of Acute Pain Service
Evolution Over the Last 2 Decades
Sheng Jia Low, MBBS, FANZCA, Stanley Sau Ching Wong, MBBS, FHKCA, FHKAM, FANZCA,
Qiu Qiu, MD, Yvonne Lee, MPHC, Timmy Chi Wing Chan, MBBS, FHKCA, FHKAM, FANZCA,
Dip Pain Mgt, Michael G. Irwin, MB, ChB, MD, FRCA, FCAI, FANZCA, FHKAM,
and Chi Wai Cheung, MBBS, MD, FHKCA, FHKAM, Dip Pain Mgt
Abstract: Acute pain services (APS) have evolved over time. Strat-
egies nowadays emphasize multimodal analgesic regimes using a
combination of nonopioid adjuvant analgesic drugs, peripheral nerve
blocks, and local anaesthetic wound infiltration where appropriate. APS
should be assessed over time to evaluate changes in outcomes which
form the basis for future development.
In this audit, data of patients under APS care in Queen Mary
hospital, Hong Kong, between 2009 and 2012 were analyzed and
compared with data from a previous audit between 1992 and 1995.
The use of patient-controlled analgesia (PCA) was increased (from
69.3% to 86.5%, P< 0.001), while the use of epidural analgesia reduced
(from 25.3% to 8.3%, P< 0.001) significantly. Although postoperative
pain scores did not improve, PCA opioid consumption and the incidence
of analgesia-related side effects were significantly less (all P< 0.001).
More patients graded their postoperative analgesic techniques used as
good when the results from these 2 audit periods were compared
(P< 0.001 and P¼ 0.001 for PCA and epidural analgesia, respectively).
In conclusion, there has been a change in analgesic management
techniques, but there has been no improvement in overall pain relief.
While changes over time have led to improvement in important
parameters such as the incidence of side effects and patient satisfaction,
further and continuous efforts and improvements are warrant to reduce
acute pain relief and suffering of the patients after the surgery.
(Medicine 94(40):e1673)
Abbreviations: APS = acute pain services, ASA = American
Society of Anesthesiologists physical status classification system,
MASTER = The Multicenter Australian Study of Epidural
Anesthesia and Analgesia in Major Surgery, NMDA = N-methyl-
D-aspartate, NRS = numerical rating scale, NSAIDs = non-steroidal
anti-inflammatory drugs, PCA = patient-controlled analgesia,
PONV = postoperative nausea and vomiting, SPSS = Statistical
Package for the Social Sciences.
INTRODUCTION
O ver 80% of patients undergoing surgery experience post-operative pain and in 39% this is severe to extreme.1 It is
well recognized that patients should be able to access best
practice care including appropriate assessment of their pain and
effective pain management strategies.2 Suboptimal acute pain
management results in various undesirable effects such as
increased risk of myocardial ischaemia or infarction, throm-
boembolic and pulmonary complications, persistent postopera-
tive pain, prolonged hospital stay, increased hospital admission,
reduced quality of life, and side effects due to analgesic con-
sumption.3–7 The first acute pain service (APS) run by anaes-
thesiologists was introduced in 19888 and such teams have since
become ubiquitous in modern healthcare.
A Hong Kong survey in 1996 identified a need for
increased resources, training, awareness, and staffing in pain
management9 and Queen Mary Hospital organized a multi-
disciplinary APS team that involved anaesthetists, pain nurses,
surgeons, and ward nurses. Eighty-six percent of the hospitals in
Hong Kong that provided anaesthetic services were running an
acute pain service by 2000.10 Our acute pain management has
expanded over the years to now include accredited pain special-
ists, full time pain nurses, and pain fellowship trainees.11
Advances inAPS include increasing emphasis on the imple-
mentation of multimodal analgesia and toward procedure-
specific management, where pain protocols are targeted to
specific surgical operations.12 Benefits in terms of postoperative
pain, incidence of adverse effects due to analgesia, quality of life,
and patient satisfaction were demonstrated with the implementa-
tion of qualitymanagement systems using procedure-specific and
multimodal pain protocols adapted to individual patients.13 Var-
ious strategies targeting the preoperative, intraoperative, and
postoperative period have been employed as part of a multimodal
analgesic regimen. Examples include the use of peripheral nerve
blocks and infusions, as well as numerous adjuvant medications
such as nonsteroidal antiinflammatory drugs (NSAIDs), para-
cetamol, ketamine, and anticonvulsants (such as pregabalin
and gabapentin).14
In view of the increased demand for pain management
services and the large number of patients utilizing the APS,
regular audit is mandatory to ensure the delivery of quality care
and demonstrate effectiveness of such treatments to facilitate
future service planning.15 The aim of this audit is to compare the
APS in Queen Mary Hospital between the epochs 2009 to 2012
and 1992 to 1995.16 More specific objectives were to identify
the changing trends of pain management modalities; evaluate
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effectiveness in terms of pain relief, morphine consumption,
and patient satisfaction; determine safety and tolerability by
comparing incidence of various complications associated with
pain management.
METHODS
This retrospective study was conducted in Queen Mary
Hospital, a tertiary referral hospital in Hong Kong, and
approved by the Institutional Review Board of the University
of Hong Kong/Hospital Authority Hong Kong West Cluster.
This study was registered at ClinicalTrials.gov (registration
number NCT02155413). Data were collected from the patient
records kept by the APS team of the Department of Anesthe-
siology, Queen Mary Hospital, Hong Kong. Data from patients
under APS care between 2009 and 2012 were collected, vali-
dated, and analyzed. These data were then compared with data
from our previous audit of the period between 1992 and 1995.
Patients were excluded from the analysis if they were ventilated
after surgery or if essential data were missing. Chronic pain
patients, opioid or sedative users or drug addicts, patients with
language barrier with difficulty in pain assessment after oper-
ation, and patients involved in other ongoing research were
also excluded.
All patients managed by the APS received one of the
postoperative analgesic regimens outlined in Table 1. They
were also managed according to a standard protocol.
Monitoring included continuous pulse oximetry for 24 h
postoperatively, hourly respiratory rate, and sedation score,
4 hourly blood pressure, pulse rate, pain scores using numeri-
cal rating scale (NRS), and analgesic related side effects
including nausea and vomiting. During the preoperative
visits, patients were given detailed information about post-
operative analgesia and asked to report any side effects
including nausea, vomiting, dizziness, pruritus, or lower limb
weakness (for epidural infusion). In addition, nursing staff
would also specifically ask about these side effects, while
charting the pain scores at 4 hourly intervals. Patients were
advised to report any other effects that they felt might be
related to their treatment.
After the operation, patients were transferred to the
recovery area where their vital signs including blood pressure,
oxygen saturation, electrocardiogram, and NRS pain scores at
rest and during cough were assessed. Pain management includ-
ing boluses of intravenousmorphine or local anaesthetic via the
epidural route would be given by the attending anaesthetist
until the NRS score was 3 or less before transfer to the
ward. Rescue pain medications and antiemetic use were also
documented.
Patients were reviewed daily. The NRS pain scores, cumu-
lative opioid or local anaesthetic use, rescue analgesics, and
complications were also documented. If patients had epidural
analgesia, bromage scores, sensory levels were noted and
insertion site inspected. When oral intake was permitted, oral
analgesics including paracetamol, NSAIDs, gabapentinoids,
and opioids were prescribed by the APS. Suitability for termin-
ation of APS review and pain management was reviewed during
the visit. Patients were then asked to grade their satisfaction on
pain management as ‘‘good,’’ ‘‘fair,’’ or ‘‘unsatisfactory’’ at
discharge from the APS service.
The APS team or on-call anaesthetist was informed if a
severe adverse event occurred. These included loss of conscious-
ness (unrousable and a sedation score of 3 or less), bradypnoea
(respiratory rate<10/min), hypotension (systolic BP< 90 mm
Hg), hypercapnoea (PaCO2> 7kPa), or oxygen desaturation
(SpO2< 90%). Management of such adverse events would
initially include cessation of analgesic technique and appropriate
resuscitation. In the event of possible opioid-induced respiratory
depression (bradypnoea, hypercapnoea, or oxygen desaturation)
that failed to resolve with simple manoeuvres, naloxone 0.2mg
could be given intravenously until resumption of normal respir-
ation with an oxygen saturation of>90%. Management of
hypotension also included administration of intravenous fluids
with intravenous ephedrine 5–10mg every 5 min as required.
Surgeons were also informed if surgical complications (e.g.,
haemorrhage) were suspected to be the cause.
Demographic data, postoperative pain scores, prevalence
of complications and adverse events, and patient-rated satis-
faction for postoperative analgesia were compared between
time periods. Parametric values were tested by t test and are
presented as meanSD. Nonparametric values were tested by
the Mann–Whitney U test and presented as median [interquar-
tile range (IQR)]. Categorical values were tested by x2 test or
Fisher exact test as appropriate and presented as number
(percentage). The significance level was set at 0.05. All analyses
were performed using Statistical Package for the Social
Sciences (SPSS) Statistics version 20 (SPSS Inc, Chicago, IL).
RESULTS
A total of 7659 records of postoperative APS patients were
audited between 2009 and 2012. Of these, 1452 (18.8%) records
were excluded from data analysis. The results of the 2009 to
2012 audit were compared with the data of a similar audit done
TABLE 1. Standard Regime for Postoperative Analgesia
Regime Drugs Loading Dose
Infusion
(mL/h)
Demand
Dose/ Lockout
Interval
1 h
Maximum
PCA Morphine 1–1.5mg every 10min
until patient is comfortable
1–1.5mg bolus.
5–10 min lockout
4.5–7.5mg
CEA Levo Bupivacaine 0.1%;
Fentanyl 2mcg/mL
Levo; Bupivacaine; 0.25–0.5%;
(4–8 mL) before skin incision
6–12mL/h Nil nil
OR Ropivacaine 0.15%
Fentanyl 2mcg/mL
Ropivacaine 0.375% (4–8mL)
before incision
6–12mL/h Nil nil
CPNB (femoral catheter) Ropivacaine 0.2% 5–10mL/h Nil nil
CEA¼ continuous epidural analgesia; CPNB¼ continuous peripheral nerve block; PCA¼ patient-controlled analgesia.
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the same centre between 1992 and 1995. For the purpose of
clarity in presentation these audits will henceforth be referred to
as audit 1 (1992–1995) and audit 2 (2009–2012).
Patient Demographic and Surgery Types
Demographic data of audit 1 and audit 2 was shown at
Table 2. While gynaecological surgeries (22.9%) were the most
frequent surgery requiring APS in audit 1, limb surgeries were
the most frequent in audit 2 (Figure 1). There was also a 7.2%
increase in the number of patients aged over 65 years using APS
(P< 0.001). More than 50% of the patients undergoing either
colorectal, hepatobiliary, or limb surgeries were above 65 years.
Mean body weight increased from 55.8 kg to 60.3 kg
(P< 0.001) over the last 2 decades. The proportion of American
Society of Anesthesiologists physical status classification sys-
tem (ASA) II and III patients using APS also increased by 4.2%
and 8.9%, respectively. The proportion of emergency surgery
also increased significantly from 5.1% to 13.7%.
Postoperative Analgesic Techniques
Postoperative analgesic techniques used are described in
Table 3. There was a significant increase in PCA use from
69.3% to 86.5% (P< 0.001). Epidural use decreased markedly
from 25.3% to 8.3% (P< 0.001) and the majority of its use
recently was in upper gastrointestinal surgery with an increase
from 10.7% to 27.8% (P< 0.001). Peripheral nerve block use
has been routinely documented since 2009, with 2.6% of
operations from 2009 to 2012 applying it and majority of its
use occurring in limb surgery. Intramuscular injections dimin-
ished significantly from 90% to 1% in the latest audit.
Duration of APS Use, Opioid Consumption, and
NRS Pain Scores
Duration of postoperative PCA and epidural use has
increased by 5.4 and 37 h, respectively (all P< 0.001,
Table 4). Morphine consumption (for PCA use) in audit 2
decreased from a mean of 49.6 to 36.2mg (P< 0.001). The
mean NRS pain scores when coughing at day 2 to day 3
postoperatively with PCA use were higher (P< 0.001) in audit
2 than audit 1. For patients receiving epidural analgesia, patient-
reported NRS pain scores at rest were higher on days 2 and 3 in
audit 2 (P< 0.025 and P< 0.001 respectively, Table 5)
Common Side Effects and Serious Adverse
Events
There was no bradypnoea or hypoxia, and hypotension
decreased from 1.0% to 0.1% between audits 1 and 2
(P< 0.001, Table 6). There was a significantly lower incidence
of hypotension and lower limb weakness following epidural use
(all P< 0.001).
The incidence of all adverse events following PCA use
decreased recently. There was a statistically significant
TABLE 2. Patient Demographic
2009–2012
(n¼ 6207)
1992–1995
(n¼ 2319) P Value
Age (mean) 58.9 54.5 <0.001
Body weight (mean kg) 60.3 55.8 <0.001
ASA I 14.3 27.4 <0.001
ASA II 54.4 50.2
ASA III 30.4 21.5 <0.001
Emergency surgery 13.7 5.1 <0.001
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FIGURE 1. Different types of operation performed in 1992–1995 and 2009–2012.
TABLE 3. Distribution of Analgesic Techniques Used
2009–2012 1992–1995 P Value
PCA 5524 (86.5) 1606 (69.3) <0.001
EPI 518 (8.3) 586 (25.3) <0.001
PNB 164 (2.7) 0 (0.0) N.A.
IM I (0.02) 90 (3.9) N.A.
IV 0 (0.0) 37 (1.6) N.A.
Data in n (%). EPI¼ epidural; IM¼ intramuscular; IV¼ intravenous;
PCA¼ patient-controlled analgesia; PNB¼ peripheral nerve block.
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reduction in dizziness, pruritus, nausea, vomiting, and rescue
antiemetic use (all P< 0.001, Table 7). For epidural use,
patients also reported less pruritus, nausea, vomiting, and rescue
antiemetic use (P< 0.001, Table 7).
Patient-Rated Satisfaction
Despite higher pain scores in audit 2, 87.5% rated the PCA
technique as good compared with only 80.4% in audit 1
(P< 0.001, Table 8). Significantly fewer patients reported their
postoperative PCA analgesic technique as fair or unsatisfactory
(P< 0.001, Table 8). There was no statistically significant
difference in the patient-rated satisfaction on epidural analgesia
between the 2 time periods.
DISCUSSION
PCA has become the most commonly used analgesic
technique now, but with a lower morphine consumption. Per-
ipheral nerve block is gaining popularity. Postoperative pain
scores were not improved whether PCA or epidural analgesia
was used. Common side effects such as dizziness, nausea, and
vomiting, as well as serious adverse events such as hypotension,
bradypnoea, and hypoxia, were significantly reduced. Although
patients reported higher satisfaction with PCA use, the same
was not shown with epidural analgesia.
Formal establishment of the APS in Queen Mary Hospital,
Hong Kong, took place in 1990. From 1992–1995 to 2002–
2005, this service evolved with recruitment of more staff,
including pain specialists and pain nurses. Modern acute pain
management advocates the development of an APS team that
TABLE 4. Duration of Different Postoperative Analgesic Tech-
niques and the Number of Patients on Different Postoperative
Analgesia in the First 3 Days
2009–2012 1992–1995 P Value
PCA
Duration (h) Mean 51.7 46.3 <0.001
Day 1 n (%) 5524 (100.0) 1606 (100.0)
Day 2 n (%) 4299 (77.8) 1310 (81.6)
Day 3 n (%) 2237 (40.5) 451 (28.1)
EPI
Duration (h) Mean 82.3 45.3 <0.001
Day 1 n (%) 518 (100) 586 (100)
Day 2 n (%) 510 (98.5) 479 (81.7)
Day 3 n (%) 493 (95.2) 137 (23.4)
EPI¼ epidural; PCA¼ patient-controlled analgesia.
TABLE 5. Mean Pain Scores (Using NRS From 0 to 10) During
the First, Second, and Third 24 Postoperative Hours Using
Postoperative Analgesic
2009–2012 1992–1995 P Value
PCA
Day 1 Rest 2.3 2.6 <0.001
Cough 5.3 5.1 0.051
Day 2 Rest 1.6 1.6 0.083
Cough 4.7 4.3 <0.001
Day 3 Rest 1.5 1.4 0.003
Cough 4.7 4.2 <0.001
EPI
Day 1 Rest 1.8 1.7 0.986
Cough 4.1 3.9 0.265
Day 2 Rest 1.3 1.0 0.025
Cough 3.8 3.5 0.129
Day 3 Rest 0.9 0.4 <0.001
Cough 3.5 3.3 0.768
Statistical method used: Mann–Whitney U test. EPI¼ epidural;
PCA¼ patient-controlled analgesia.
TABLE 6. Incidence of Serious Adverse Events With Different
Analgesic Techniques
2009–2012 1992–1995 P Value
PCA
Bradypnoea 0 (0.0) 6 (0.4) <0.001
Hypoxia 0 (0.0) 20 (1.2) <0.001
Reintubation 3 (0.1) 6 (0.4) 0.006
Hypotension 3 (0.1) 16 (1.0) <0.001
Confusion 16 (0.3) N.A. N.A.
EPI
Bradypnoea 0 (0.0) 2 (0.3) 0.501
Hypoxia 0 (0.0) 9 (1.5) 0.004
Reintubation 0 (0.0) 6 (1.0) 0.033
Hypotension 1 (0.2) 23 (3.9) <0.001
Lower limb weakness 1 (0.2) 98 (16.7) <0.001
PNB (only 2009–2012 data)
Lower limb weakness 0 (0.0)
Hypoxia 0 (0.0)
Data in n (%). EPI¼ epidural; PCA¼ patient-controlled analgesia;
PNB¼ peripheral nerve block.
TABLE 7. Incidence of Common Adverse Events With Differ-
ent Analgesic Techniques
2009–2012 1992–1995 P Value
PCA
Dizziness 930 (16.8) 478 (29.8) <0.001
Pruritus 195 (3.5) 132 (8.2) <0.001
Nausea 1737 (31.4) 708 (44.1) <0.001
Vomiting 685 (12.4) 396 (24.7) <0.001
Antiemetic 21 (0.4) 183 (11.4) <0.001
EPI
Dizziness 51 (9.8) 72 (12.3) 0.198
Pruritus 13 (2.5) 103 (17.6) <0.001
Nausea 82 (15.8) 172 (29.4) <0.001
Vomiting 45 (8.7) 102 (17.6) <0.001
Antiemetic 4 (0.8) 34 (5.8) <0.001
PNB (only 2009–2012 results)
Dizziness 6 (3.6)
Pruritus 0 (0.0)
Nausea 22 (13.3)
Vomiting 6 (3.6)
Antiemetic 0 (0.0)
Data in n (%). EPI¼ epidural; PCA¼ patient-controlled analgesia,
PNB¼ peripheral nerve block.
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consists of both anaesthetists and pain nurses.17 Expert super-
vision by APS staff can improve postoperative pain relief and
minimize side effects by offering patient selection and edu-
cation, training of nursing staff, and the regular assessment of
pain and treatment efficacy.18,19 The advance in pain manage-
ment techniques and pain medications with evidence-based
support also contributes.1 Acute postoperative pain manage-
ment guidelines that include information on different analgesic
techniques and postoperative monitoring have also been devel-
oped. This is reviewed and amended twice yearly based on
updated evidence. Compared with the period from 1992 to
1995, education about APS is regularly offered to medical and
nursing staff who are involved in postoperative pain manage-
ment. This study gives us an overview of the changes over the
last 2 decades and allows us to evaluate their impact. Moreover,
regular audit in our APS aids us in identifying our strengths and
potential areas for improvement.
Our demographic data suggest that our population is aging
and also gaining weight. Elderly patients commonly have
altered physiology, decreased opioid requirements, and
increased comorbidities such as dementia, with higher risk
postoperative cognitive dysfunction. Increasing numbers of
obese patients and a higher incidence of obstructive sleep
apnoea pose an increased risk of respiratory problems from
opioid use. It is, however, encouraging to note that it seemed
there was a reduction in the incidence of bradypnoea
and hypoxia.
PCA has gained popularity since its introduction in
197120–22 and is also commonly used in the elderly now as
it is safer than intramuscular injections.23 Despite increased
prescription for PCA for postoperative use, patient-reported
NRS at rest has not improved and, in fact, appears to have
increased slightly while coughing in days 2 and 3. The PCA
regime in QMH is typically programmed with morphine as the
opioid of choice, with a 1mg bolus given over 1 min, a 5 min
lockout, and an hourly upper limit of 0.1mg per kg. The hourly
limit has been adopted as it was felt that this would be safer.
This raises the question whether the slightly higher NRS pain
score is related to the presence of an hourly upper limit that
restricts the amount given to the patients, especially for those
with more major operations nowadays.24 Other potential
reasons accounting for the increase in pain scores include
patient’s fears of addiction or side effects, or PCA by itself
is inadequate in providing the best postoperative analgesia.
Macintyre and Jarvis suggested that the best predictor of
morphine consumption is the age of the patient.25 With this
in mind, adjustments to the protocol such as lifting the hourly
limit for younger patients may be necessary. With increased
ward nursing staff education, concerns regarding improper use
should diminish. It is interesting to note that, even with good
patient education, patients’ satisfaction and reported ability to
control pain is also significantly affected by their confidence
with the PCA design, with close to 50% of patients reporting not
knowing if they would receive medicine when they pushed the
PCA button.26
While NRS pain scores remain unchanged and have
increased in certain circumstances, morphine consumption
has decreased, which may be a result of adopting multimodal
analgesia and its obvious advantages in reducing opioid con-
sumption.27 Recovery may also be enhanced with less opioid
use. Regular adjuvant analgesics, including paracetamol, tra-
madol, nonsteroidal antiinflammatory drugs, and gabapenti-
noids, are more regularly prescribed to patients now once
oral intake is allowed. PCA with a combination of morphine
and ketamine for the postoperative period is not used in our
center. A review by Carstensen and colleagues showed that
there was no conclusive evidence to date to recommend post-
operative ketamine use.28 However, it may be worth consider-
ing in patients who have thoracic surgery where it has been
shown to reduce pain scores, cumulative morphine consump-
tion, and postoperative desaturation.1 As an N-methyl-D-aspar-
tate (NMDA) antagonist, it may improve the efficacy of opioids
and reduce the development of chronic pain syndromes.29 It is
commonly used in major surgery but, postoperatively, may lead
to hallucinations, nausea, dizziness, and blurred vision.
Epidural use following major surgery, especially color-
ectal, urological, gynaecological, and thoracic surgeries, has
declined significantly in the last decade. This trend could be
influenced by findings from The Multicenter Australian Study
of Epidural Anesthesia and Analgesia in Major Surgery (MAS-
TER) trial that found no differences in mortality or incidence of
major morbidity in the epidural group compared with the group
receiving intravenous opioids.30,31 Moreover, advances in
analgesic techniques and medications can help offer better
postoperative analgesia, which make the choice of using epi-
dural analgesia less favorable as epidural analgesia is not
without risk and disadvantage. There was, however, a statisti-
cally significant increase in epidural use in upper gastrointes-
tinal surgery. Significant postoperative pain, discomfort on
coughing, patient’s inability to have oral medications for longer
periods, and the desire to avoid nausea and vomiting related to
opioid use would have influenced the anaesthetist’s choice to
choose an epidural in such circumstances.
Peripheral nerve block techniques have also gained popu-
larity over the last few years, especially in limb surgeries. Now,
there have been interesting technologic advances such as ultra-
sound-guided peripheral nerve blocks and also declining trends
on epidural analgesia, which is also based on the results of pain
research in regional analgesia and anaesthesia. The increasing
availability of ultrasound and well-described techniques have
heralded a surge in ultrasound-guided peripheral nerve
blocks.32 While use of ultrasound has been associated with
an increased overall success rate when compared with nerve
TABLE 8. Patient-Rated Satisfaction With Different Analgesic
Techniques
2009–2012 1992–1995 P Value
PCA
Good 4276 (87.5) 1266 (80.4) <0.001
Fair 512 (10.5) 242 (15.4) <0.001
Unsatisfactory 8 (0.2) 16 (1.0) <0.001
Unknown 90 (1.8) 51 (3.2) <0.001
EPI
Good 412 (92.8) 500 (85.9) 0.001
Fair 30 (6.8) 62 (10.7) 0.030
Unsatisfactory 1 (0.2) 6 (1.0) 0.120
Unknown 1 (0.2) 14 (2.4) 0.004
PNB (2009–2012 only)
Good 134 (92.4)
Fair 9 (6.2)
Unsatisfactory 0 (0.0)
Unknown 2 (1.4)
Data in n (%). EPI¼ epidural; PCA¼ patient-controlled analgesia;
PNB¼ peripheral nerve block.
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stimulation, there is no proven research that ultrasound gui-
dance reduces complication rates such as neurologic inju-
ries.33,34 Whether an increase in the use of regional blocks
for analgesia after surgery improves pain relief and enhances
recovery requires further study.
Side effects from PCA are a major concern for patients and
medical staff.20,21 With increasing experience, staff, and patient
education, the prevalence of dizziness, pruritus, nausea, and
vomiting has shown a statistically significant decline. The side
effect that is most prevalent of these is nausea, with 31.9% of
patients still experiencing it with PCA use, which is consistent
with findings from other centres.35,36 Metoclopramide was used
for the management of postoperative nausea and vomiting
(PONV) in the 1990s. A regime of intraoperative dexametha-
sone and ondansetron for patients in high-risk of PONV has
been adopted. Identification of patients at higher risk of PONV
and concomitant use of nonopioid-based analgesia has seen a
significant decrease of this side effect. Propofol-based total
intravenous anaesthesia has also become very popular in our
center over the last decade and will reduce the incidence of
PONV. However, even though a decrease in incidence was
observed, the rate is still unacceptable and more work needs to
be done.36
The most common side effect with epidural analgesia is
also nausea and vomiting with 15.5% and 8.9% experiencing
it. This could be related to opioid (fentanyl) in the infusion
and also from hypotension that is exacerbated by sympatho-
lysis from epidural analgesia, although the prevalence of
hypotension following epidural analgesia has decreased to
only 0.2% from 3.9% in 1992 to 1995. Likewise, the preva-
lence of lower limb weakness also decreased to 0.2% from
16.7%. This could be due to the use of lower concentrations of
local anaesthetic namely 0.2% ropivacaine and 2 mcg/mL
fentanyl that is used in our institution. A change from bupi-
vacaine (1992–1995) to ropivacaine (2009–2012) for epi-
dural infusion may also account for a lower incidence of lower
limb weakness.
In 2009 to 2012, bradypnoea and hypoxia was not reported
and hypotension decreased from 1.0% to 0.1% in patients
prescribed PCA. There is now more than 20 years of experience
in PCA use and PCA is now commonly prescribed. There are a
few potential reasons accounting for the improved safety in this
study. An hourly upper limit is set for PCA use. In fact, there is a
lack of evidence that patients benefit from an hourly upper dose
limit,24 but this has been kept to increase patient safety.
However, again, the hourly limit may attribute partially to
the inferior pain relief. Regular multimodal analgesia with
nonopioid analgesics has resulted in less opioid consumption.
Education to the medical and nursing staff, as well as patients,
about PCA has also led more appropriate and correct use of
PCA. It can also help in identifying potential adverse events or
complications earlier.
In general, there was a significant increase in patient
satisfaction with analgesic techniques. However, we are cau-
tious that such reports could be misleading as patients are often
reluctant to criticize their treatment after surgery and when their
satisfaction is also related to their expectation of pain relief,
communication skills, and empathy expressed by health care
providers.37–39
In conclusion, our current audit results show that post-
operative pain management techniques have been changed with
time. Although postoperative opioid consumption and side
effects were reduced, such changes did not lead to better pain
relief after operation. Further and continuous efforts and
improvements are warrant to reduce acute pain relief and
suffering of the patients after the surgery.
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